Cannabis Startups and Investing Series

16340

What are the medicinal benefits of cannabinoids?

THC, CBD, and over a hundred related chemicals play a role in how your body works

Innovation series by Ronny Kerr
July 28, 2016
Short URL: http://vator.tv/n/46a7

Note: The CannaVator accelerator, which includes a 10-week online and in-person program, is accepting applications until August 15, 2016 for its Fall 2016 cohort. More details about the program and how to apply here.

Ask people on the street about the effect cannabis has on your mind and body, and you’re bound to hear a wide range of answers.

“It gets you high.”

“It makes you feel good.”

“It makes you hungry.”

“It makes you feel paranoid.”

“It eases your pain.”

And yet your everyday person probably doesn’t understand why cannabis effects such varied experiences. The answer is in the cannabinoids.

Cannabinoids make up a group of diverse yet closely related chemical compounds that interact with cannabinoid receptors throughout the mammalian body. In other words, the body has built-in mechanisms for producing and processing cannabinoids. The endocannabinoid system, with receptors in the brain and throughout the body's nervous system, plays a role in various physiological and psychological processes, including appetite, awareness of time, body movement, concentration, memory, mood, the sensations of pain and pleasure, and overall thinking.

As you’ve probably already guessed, it’s not just our bodies that produce cannabinoids; cannabinoids also happen to be the active chemicals in cannabis, or marijuana.

THC

Among over a hundred cannabinoids, the most famous is tetrahydrocannabinol (THC), which has been identified as the component of cannabis principally responsible for the substance's psychoactive effects. Nevertheless, though THC is the cannabinoid most responsible for altering the minds of cannabis users, the chemical is not without its health benefits.

In fact, two THC-based pills have already been approved by the U.S. Food and Drug Administration (FDA): dronabinol and nabilone (brand names: "Marinol" and "Cesamet"), which contain synthetically-created chemicals instead of chemicals extracted from plants, are used to treat nausea and vomiting associated with cancer chemotherapy. Dronabinol is also used to treat loss of appetite that leads to weight loss in people with AIDS.

The National Institutes of Health (NIH) says THC-based medicine may also prove useful in decreasing pain, inflammation (swelling and redness), and muscle control problems.

CBD and beyond

Another major constituent of cannabis, and one that has proven even more promising for its health benefits, is cannabidiol (CBD). It's not just that CBD has medical applications; the chemical is promising because it doesn't induce the same psychoactive effects that THC does, meaning the consumer or patient wouldn't experience typical problems with “highness” or other potentially undesirable side effects associated with THC.

Though the THC-based pills described above (dronabinol and nabilone) are the only cannabinoid-based drugs currently approved by the FDA, CBD could end up being the more prominent cannabinoid in future medicinal drugs. According to the NIH:

“There is growing interest in the marijuana chemical cannabidiol (CBD) to treat certain conditions such as childhood epilepsy, a disorder that causes a child to have violent seizures. Therefore, scientists have been specially breeding marijuana plants and making CBD in oil form for treatment purposes. These drugs may be less desirable to recreational users because they are not intoxicating.”

Besides all the above medicinal benefits of THC and CBD, the two cannabinoids (as well as many others) have been identified as useful in treating a wide variety of ailments and illnesses.

In order to quality for medicinal cannabis in the states where medicinal use of cannabis has been legalized, a patient must have a qualifying condition. According to the 2016 U.S. Cannabis Investment Report by Ackrell Capital, over 40 such conditions have been designated by various state laws. Here is a chart from Ackrell’s report identifying 20 of the most common qualifying conditions that are treated with cannabinoids:



Expectedly, THC and CBD are commonly used to treat the majority of conditions. Additionally, as Ackrell notes in its report, qualifying conditions are often described as “serious” or “debilitating.”

As stated earlier, THC and CBD are just two of over a hundred cannabinoids active in the cannabis plant. Furthermore, laboratories have successfully produced synthetic cannabinoids based on the structure of natural cannabinoids found in cannabis plants. Between the other natural cannabinoids and lab-created analogs, there are still many opportunities to discover additional beneficial, medical applications of cannabinoids.


Related companies, investors and entrepreneurs

10665
Ackrell Capital, LLC
Service provider
Description: Ackrell Capital is an investment bank founded by senior technology investment bankers and entrepreneurs. We are headquartered in San Fran...

Related news

Get-listed-300x250

Featured Stories

Mbp-300x250

Other episodes of this series

Election 2016: 4 new states legalize...

18466

Cannabis Startups and Investing Series

by Steven Loeb
Only Arizona voted no, while North Dakota, Florida, Arkansas and Montana expanded medicinal use

On demand cannabis delivery service Eaze...

18379

Cannabis Startups and Investing Series

by Steven Loeb
The company will use the funding to expand to new markets in California

Where do Trump and Clinton stand on cannabis?

18355

Cannabis Startups and Investing Series

by Ronny Kerr
Though the GOP candidate's a wild card, neither seems eager to crack down on legal cannabis markets

The cannabis space set to see first annual...

18357

Cannabis Startups and Investing Series

by Steven Loeb
Cannabis companies saw the amount invested drop 68 percent in Q3, lowest since Q3 2015

Why Mark Cuban won't invest in cannabis

18296

Cannabis Startups and Investing Series

by Steven Loeb
The majority of his fellow Shark Tank hosts also don't see cannabis as a good investment
Splashx_health1_320x240